|
End-of-day quote
Nasdaq
27/10/2026
|
5-day change | 1st Jan Change | ||
| 13.04 USD | +2.52% |
|
-6.92% | +0.08% |
| 10-20 | Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC | CI |
| 10-20 | Freenome Launches SimpleScreen Lung Cancer Test | MT |
Company Valuation: Freenome, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 144.2 | 1,444 | - | - |
| Change | - | 901.38% | - | - |
| Enterprise Value (EV) | 144.2 | 1,444 | 1,444 | 1,444 |
| Change | - | 901.38% | 0% | 0% |
| P/E | -1.57x | -6.82x | -6.02x | -5.92x |
| PBR | - | - | - | - |
| PEG | - | 0.1x | -0.5x | -3.61x |
| Capitalization / Revenue | - | 14.1x | 12.7x | 6.94x |
| EV / Revenue | - | 14.1x | 12.7x | 6.94x |
| EV / EBITDA | - | 1,605x | -8.17x | -8.66x |
| EV / EBIT | - | -12.4x | -6.72x | -8.41x |
| EV / FCF | - | -10.8x | -9.06x | -24.7x |
| FCF Yield | - | -9.29% | -11% | -4.05% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -8.28 | -1.97 | -2.233 | -2.27 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 102.4 | 113.8 | 208.1 |
| EBITDA 1 | - | 0.9 | -176.8 | -166.7 |
| EBIT 1 | - | -116.1 | -214.8 | -171.8 |
| Net income 1 | -219.3 | -175.1 | -245.7 | -257.7 |
| Net Debt | - | - | - | - |
| Reference price 2 | 13.03 | 13.44 | 13.44 | 13.44 |
| Nbr of stocks (in thousands) | 11,068 | 107,447 | - | - |
| Announcement Date | 3/30/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.82x | - | - | - | 1.44B | |
| 16.92x | 6.39x | 12.26x | 1.77% | 64.14B | |
| 30.57x | 8.11x | 26.59x | 0.05% | 55.53B | |
| 36.68x | 6.52x | 19.45x | 0.88% | 53.03B | |
| 35.39x | 3.41x | 14.74x | -.--% | 45.99B | |
| 49.25x | 5.68x | 31.09x | -.--% | 42.45B | |
| -19.59x | 189.6x | -20.86x | -.--% | 40.45B | |
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | |
| 47.12x | 8.37x | 28.08x | -.--% | 34.47B | |
| 27.96x | 5.9x | 15.29x | -.--% | 24.23B | |
| Average | 24.92x | 26.89x | 16.40x | 0.34% | 39.4B | |
| Weighted average by Cap. | 27.84x | 25.38x | 16.46x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FRNM Stock
- Valuation Freenome, Inc.
Select your edition
All financial news and data tailored to specific country editions
